Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lichter

Showing results (321-330 of 339) with videos related to

Pageof 34
Sort By:
Cancer Discovery|August 10, 2021
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence TargetsCornelis M van Tilburg, Elke Pfaff, Kristian W Pajtler, et al.
Cancer Cell|October 20, 2012
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastomaDominik Sturm, Hendrik Witt, Volker Hovestadt, et al.
Nature|August 16, 2013
Signatures of mutational processes in human cancerLudmil B Alexandrov, Serena Nik-Zainal, David C Wedge, et al.
Cancer Cell|March 22, 2014
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibitionMarcel Kool, David T W Jones, Natalie Jäger, et al.
Nature|December 21, 2017
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profilingStephen C Mack, Kristian W Pajtler, Lukas Chavez, et al.
Nature Genetics|April 11, 2017
Spatial heterogeneity in medulloblastomaA Sorana Morrissy, Florence M G Cavalli, Marc Remke, et al.
Nature Communications|December 10, 2015
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencingTyler S Alioto, Ivo Buchhalter, Sophia Derdak, et al.
Nature|March 1, 2018
The landscape of genomic alterations across childhood cancersSusanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, et al.
Nature|June 8, 2018
Author Correction: The landscape of genomic alterations across childhood cancersSusanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, et al.
Nature|July 22, 2014
Enhancer hijacking activates GFI1 family oncogenes in medulloblastomaPaul A Northcott, Catherine Lee, Thomas Zichner, et al.
Pageof 34

Showing results (321-330 of 339) with videos related to

Sort By:
Pageof 34
Cancer Discovery|August 10, 2021
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence TargetsCornelis M van Tilburg, Elke Pfaff, Kristian W Pajtler, et al.
Cancer Cell|October 20, 2012
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastomaDominik Sturm, Hendrik Witt, Volker Hovestadt, et al.
Nature|August 16, 2013
Signatures of mutational processes in human cancerLudmil B Alexandrov, Serena Nik-Zainal, David C Wedge, et al.
Cancer Cell|March 22, 2014
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibitionMarcel Kool, David T W Jones, Natalie Jäger, et al.
Nature|December 21, 2017
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profilingStephen C Mack, Kristian W Pajtler, Lukas Chavez, et al.
Nature Genetics|April 11, 2017
Spatial heterogeneity in medulloblastomaA Sorana Morrissy, Florence M G Cavalli, Marc Remke, et al.
Nature Communications|December 10, 2015
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencingTyler S Alioto, Ivo Buchhalter, Sophia Derdak, et al.
Nature|March 1, 2018
The landscape of genomic alterations across childhood cancersSusanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, et al.
Nature|June 8, 2018
Author Correction: The landscape of genomic alterations across childhood cancersSusanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, et al.
Nature|July 22, 2014
Enhancer hijacking activates GFI1 family oncogenes in medulloblastomaPaul A Northcott, Catherine Lee, Thomas Zichner, et al.
Pageof 34